What is CVE-2024-33871?

CVE-2024-33871 is a high-severity vulnerability in Artifex Ghostscript, classified under Code Injection. CVSS score: 8.8/10. Published 2024-07-03.

How severe is CVE-2024-33871?

High severity. CVSS v3 base score is 8.8 out of 10.

Is CVE-2024-33871 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

RCE in Artifex Ghostscript

CVE-2024-33871

An issue was discovered in Artifex Ghostscript before 10.03.1. contrib/opvp/gdevopvp.c allows arbitrary code execution via a custom Driver library, exploitable via a crafted PostScript document. This occurs because the Driver parameter for…

Vulnerability class: RCE (Remote Code Execution)

EPSS: 0.014 (70.2th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H.

Affected products

Artifex Ghostscript
N/a — versions n/a

Weakness classification (CWE)

CWE-94 — Code Injection

Public proof-of-concept exploits

Romern/Romern

References

cve@mitre.org (Issue Tracking)
cve@mitre.org (Patch)
cve@mitre.org (Mailing List)

Frequently asked questions

What is CVE-2024-33871?: CVE-2024-33871 is a high-severity vulnerability in Artifex Ghostscript, classified under Code Injection. CVSS score: 8.8/10. Published 2024-07-03.
How severe is CVE-2024-33871?: High severity. CVSS v3 base score is 8.8 out of 10.
Is CVE-2024-33871 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.